Evidence map›Paper›PMID 17513579›Full record

ArticleApplied and environmental microbiology2007

Development of experimental genetic tools for Campylobacter fetus.

Sabine Kienesberger, Gregor Gorkiewicz, Martina M Joainig, Sylvia R Scheicher, Eva Leitner, Ellen L Zechner

Abstract readEvaluation Study
In one paragraph

Article in Applied and environmental microbiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Fic Proteins ofFrontiers in microbiology · 2017
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sabine KienesbergerInstitut für Molekulare Biowissenschaften, Karl-Franzens-Universität, Universitätsplatz 2, A-8010 Graz, Austria.
Gregor Gorkiewicz
Martina M Joainig
Sylvia R Scheicher
Eva Leitner
Ellen L Zechner

Funding

Austrian Science Fund FWF P 18607
6 · The paper itself

Abstract

Molecular analysis of the virulence mechanisms of the emerging pathogen Campylobacter fetus has been hampered by the lack of genetic tools. We report the development and functional analysis of Escherichia coli-Campylobacter shuttle vectors that are appropriate for C. fetus. Some vectors were constructed based on the known Campylobacter coli plasmid pIP1455 replicon, which confers a wide host range in Campylobacter spp. Versatility in directing gene expression was achieved by introducing a strong C. fetus promoter. The constructions carry features necessary and sufficient to detect the expression of phenotypic markers, including molecular reporter genes in both subspecies of C. fetus, while retaining function in C. jejuni. The capacity to express several gene products from different vectors in a single host can be advantageous but requires distinct plasmid replicons. To this end, replication features derived from a cryptic plasmid of C. fetus subsp. venerealis strain 4111/108, designated pCFV108, were adapted for a compatible series of constructions. The substitution of the C. coli replication elements reduced vector size while apparently limiting the host range to C. fetus. The complementation of a ciprofloxacin-resistant mutant phenotype via vector-driven gyrA expression was verified. Cocultivation demonstrated that shuttle vectors based on the pCFV108 replicon were compatible with pIP1455 replication functions, and the stable maintenance of two plasmids in a C. fetus subsp. venerealis host over several months was observed. The application of both vector types will facilitate the investigation of the genetics and cellular interactions of the emerging pathogen C. fetus.

Indexed as

Genetic TechniquesGenetic VectorsAnti-Bacterial AgentsCampylobacter coliCampylobacter fetusCampylobacter jejuniCiprofloxacinConjugation, GeneticDNA, BacterialDrug Resistance, BacterialEscherichia coliGene ExpressionGenes, ReporterGenetic Complementation TestGreen Fluorescent ProteinsMicroscopy, ConfocalAnti-Bacterial AgentsCiprofloxacinDNA, BacterialGreen Fluorescent Proteins

Identifiers

PMID17513579
PMCPMC1932827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.